Jennison Associates
TTPH

Jennison Associates’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Jennison Associates’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-56,141
Closed -$53.3M – 787
2015
Q2 		$53.3M Buy
56,141
+458
+0.8% +$374K 0.05% 326
2015
Q1 		$40.8M Sell
55,683
-305
-0.5% -$229K 0.04% 360
2014
Q4 		$44.5M Buy
55,988
+23,582
+73% +$12.7M 0.04% 344
2014
Q3 		$12.9M Buy
32,406
+49
+0.2% +$13.1K 0.01% 469
2014
Q2 		$8.73M Sell
32,357
-3,940
-11% -$846K 0.01% 485
2014
Q1 		$7.91M Buy
36,297
+122
+0.3% +$34K 0.01% 499
2013
Q4 		$9.78M Sell
36,175
-9,899
-21% -$2.36M 0.01% 487
2013
Q3 		$10.5M Buy
46,074
+499
+1% +$87.2K 0.01% 476
2013
Q2 		$6.41M Buy
+45,575
New +$7.22M 0.01% 481

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Jennison Associates's TTPH Position: Q3 2015 in Review

Jennison Associates sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 56,141 shares — an estimated $53.3M sold.

Jennison Associates first reported a position in TTPH in Q2 2013 and held it in 9 quarters. The position peaked at $53.3M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • Jennison Associates reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Jennison Associates sold 56,141 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $53.3M.
  • Jennison Associates first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
  • Jennison Associates's Tetraphase Pharmaceuticals, Inc. position peaked at $53.3M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.